| Cell therapy for left ventricular remodeling. | |
| | |
MedLine Citation:
|
PMID: 17386179 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The increasing longevity of patients with heart failure (HF) and the rise in the incidence of HF has created an urgent need to effectively treat and prevent left ventricular remodeling. Within the past 6 years, skeletal myoblast and bone marrow mononuclear cell transplantation have been undertaken in over 200 patients with HF, geared to the underlying injury, not just its mechanisms. Early safety/feasibility studies showed promising but somewhat conflicting secondary symptomatic and functional improvements, and safety concerns have arisen. However, the patient population, cell type, dose, time, mode of delivery, and outcome measures differed-making comparisons problematic. It is now time to: 1) create a central registry of all patients treated with cells; 2) perform side-by-side comparisons of different types of cells in patients with similar HF states; 3) agree on standardized trial designs; and 4) define acceptable and unacceptable outcomes (and measures) compared with both standard of care and to other emerging therapies. By doing so, we can avoid the pitfalls that previous biologics (eg, angiogenic gene therapy) have suffered, increase the likelihood of success, shorten the time-to-presentation of cell-based algorithms to clinicians, and deliver these therapies to patients who await new ways of reduction of symptoms and improvement of quality of life. |
| | |
Authors:
|
Doris A Taylor; Andrey G Zenovich |
Related Documents
:
|
9805259 - Effect of beta-blocker treatment in dilated cardiomyopathy with bradyarrhythmias. 12585949 - Effects of initiating carvedilol in patients with severe chronic heart failure: results... 14565809 - Cardiorespiratory effects of naloxone in children. 11325669 - Long-term comparison between perindopril and nifedipine in normotensive patients with t... 19655819 - Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analys... 19909879 - Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension. 18805609 - Associations of dialysis modality and infectious mortality in incident dialysis patient... 21622219 - Effect of thymectomy on cellular immune function. 22989869 - Quality of life and survival in patients with heart failure. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Current heart failure reports Volume: 4 ISSN: 1546-9530 ISO Abbreviation: Curr Heart Fail Rep Publication Date: 2007 Mar |
Date Detail:
|
Created Date: 2007-03-27 Completed Date: 2007-08-17 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 101196487 Medline TA: Curr Heart Fail Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 3-10 Citation Subset: IM |
Affiliation:
|
Department of Integrative Biology/Physiology, University of Minnesota, 312 Church Street SE, 7-105A Nils Hasselmo Hall, Minneapolis, MN 55455, USA. dataylor@umn.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bone Marrow Transplantation* Clinical Trials as Topic Heart Failure / physiopathology*, surgery, therapy* Humans Myoblasts, Skeletal / transplantation* Research Design Stroke Volume Ventricular Remodeling* |
| Grant Support | |
ID/Acronym/Agency:
|
R01-HL-063346/HL/NHLBI NIH HHS |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [The in vivo and in vitro effects on neovascularization of VEGF gene transfer with a new pseudotyped...
Next Document: Remodeling of excitation-contraction coupling in the heart: inhibition of sarcoplasmic reticulum Ca(...